PhD in Synthetic Biomaterials for Corneal Applications at Radboud University (Regenerative Medicine, Materials Science, Cell Biology) Radboud University in Netherlands

Radboud University’s Faculty of Science in the Netherlands is offering a fully funded PhD position in the development of animal-free synthetic biomaterials for corneal applications, as part of the MSCA STEM-CORE network. The successful candidate will join the Paul Kouwer Lab, specializing in the design and biomedical application of hydrogels and other soft materials. The research focuses on creating and characterizing synthetic biomaterials, such as PIC gels, for use in corneal cell culture and regenerative medicine.

The PhD project involves interdisciplinary work at the interface of chemistry, materials science, and cell biology. The candidate will split their time between chemistry/analytical labs (synthesizing and characterizing gels) and cell culture labs (applying these materials in biological contexts). Collaboration is a key aspect, with opportunities to work closely with Prof. Zhou’s group at Radboud University Medical Center and to engage with STEM-CORE fellows across Europe through joint projects, secondments, and network training activities.

Applicants should have or expect to obtain a Master’s degree in life sciences, chemistry, biomolecular sciences, or a related field. Experience in cell biology is required, and familiarity with 3D cell biology, materials science, or chemistry is advantageous. Candidates should demonstrate curiosity, critical thinking, strong communication skills, and the ability to work both independently and in teams. Excellent English proficiency is essential. The position is open to international candidates, but applicants must comply with MSCA mobility rules (not having lived or worked in the Netherlands for more than 12 months in the last 36 months).

The position offers a competitive salary (€3,059–€3,881 gross/month), an 8% holiday allowance, an 8.3% year-end bonus, and generous leave (30–41 days/year). Additional benefits include flexible work-life arrangements, a 34% discount on sports and cultural activities, a pension plan, and extensive training and networking opportunities across Europe. The initial contract is for 1.5 years, extendable to 4 years upon positive evaluation. The preferred start date is 1 July 2026, with the application deadline on 8 March 2026.

To apply, candidates should submit their application via the Radboud University portal, addressing their letter to Dr. Paul Kouwer. For further information, contact Dr. Kouwer at [email protected]. This opportunity is ideal for those passionate about regenerative medicine, biomaterials, and translational research in an international, collaborative environment.